Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) |
| BNF code | 1501060N0AAAAAA |
| Virtual Medicinal Product | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules |
| Name | Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules |
| Abbreviated name | Neostigmine 2.5mg/Glycopyrronium brom 500microg/1ml inj amp |
| Supplier | Martindale Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| Previous licensing authority | None |
| Reason for change of licensing authority | No Reason Available |
| Date of change of licensing authority | 20 Nov 2008 |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Neostigmine 2.5mg/1ml / Glycopyrronium bromide 500micrograms/1ml solution for injection ampoules (Martindale Pharmaceuticals Ltd) 10 ampoule | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.